35 results on '"Gemcitabine -- Complications and side effects"'
Search Results
2. Studies from Ente Ospedaliero Cantonale (EOC) in the Area of Pancreatic Cancer Published (Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?)
3. University Hospital Researchers Provide New Study Findings on Pancreatic Cancer [Integrated Analysis of the RASH Study with the Use of the 'Burden of Therapy' (BOTh[superscript]®TM) Methodology-A Novel Tool for Assessing Adverse Events in Me
4. Study Findings from University of La Frontera Broaden Understanding of Gallbladder Cancer (A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance)
5. Reports from Department of Oncology Advance Knowledge in Bladder Cancer (Clinical Efficacy of Intravesical Gemcitabine Combined With Ubenimex In Patients With Non-muscle-invasive Bladder Carcinoma After Transurethral Resection of Bladder Tumor)
6. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
7. Factors potentially associated with gemcitabine-based chemotherapy-induced thrombocytopenia in Chinese patients with nonsmall cell lung cancer
8. Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer
9. Phase I/II Study of Gemcitabine and Vinorelbine Plus Cisplatin in Non-Small Cell Lung Cancer
10. The Evaluation of Gemcitabine in Resistant or Relapsing Multiple Myeloma, Phase II: a Southwest Oncology Group Study
11. Achievement of Complete Remission in Refractory Hodgkin's Disease with Prolonged Infusion of Gemcitabine
12. Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
13. Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
14. Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3
15. A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors
16. A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma
17. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study
18. Shortness of breath and hypoxemia after chemotherapy with carboplatin and gemcitabine
19. Gemcitabine and acute myocardial infarction: a case report
20. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project
21. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma
22. Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation
23. Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma. A phase-II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)
24. Nanoparticles extend survival in pancreatic ca patients
25. 'The best level 1 evidence available'
26. Adjuvant gemcitabine improves outcomes of pancreatic ca: final results of the CONKO-001 trial show significant gains in both disease-free survival and overall survival with this chemotherapy
27. An unusual etiology of vascular toxicity and its treatment with cervical sympathetic blockage
28. Data Presented at ASCO 2016 Builds upon Foundation of Abraxane[R] Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer
29. Data Presented at ASCO GI Highlight the Feasibility of Second-Line Treatment in Patients with Metastatic Pancreatic Cancer Who Have Received First-Line Abraxane Plus Gemcitabine
30. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
31. Gemcitabine: hemolytic syndrome
32. Gemcitabine and Carboplatin: A Well-Tolerated Active Combination for Advanced N
33. Is there a Better Way to Give Gemcitabine?
34. Cost-Effectiveness of Bone Marrow Transplantation for Chronic Myeloid Leukemia
35. Gemcitabine Plus Cisplatin in Non-Small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.